Etop Ibcsg Partners Foundation

This trial is testing whether a powerful combination of immunotherapy, chemotherapy, and targeted radiation can better control advanced lung cancer that has spread to only a few other body sites. It involves 96 adults with untreated stage IV non-small cell lung cancer. The goal i…

This study is testing whether adding two drugs (amivantamab and bevacizumab) to a continued targeted therapy (lazertinib) can help control advanced lung cancer that has started growing again after previous treatment. It will involve about 60 patients with a specific genetic chang…

This trial is testing a pill called adagrasib for people with advanced lung cancer that has a specific genetic change called KRAS G12C. It focuses on patients who are 70 or older or who are in poorer health, groups often left out of other studies. The main goal is to see if the p…

This study investigates whether young women with hormone-sensitive early breast cancer can safely pause their hormone-blocking therapy to try to become pregnant. It follows over 500 participants to see if this treatment break increases the risk of the cancer coming back. The rese…